In a groundbreaking decision, President Trump is poised to sign an executive order reclassifying marijuana to Schedule III, easing federal restrictions and paving the way for vital medical research. This move aims to benefit Americans suffering from chronic pain and other conditions.
President Trump is reviewing the federal classification of marijuana, a potential game-changer for its regulation and taxation. Could this lead to legal changes that reflect state laws?
In a surprising move, Trump announces he is considering reclassifying marijuana, potentially paving the way for legalization and impacting cannabis stocks. What does this mean for the future of cannabis in America?
President Trump hints at reclassifying marijuana as a less dangerous drug, potentially shifting its status from Schedule 1 to Schedule 3. This decision could open doors for research and tax benefits for the cannabis industry.
In a surprising announcement, Trump revealed plans to reclassify marijuana from a Schedule I to a Schedule III drug, which could significantly impact the cannabis market and investor interest. Experts predict that this change could take about a year, but optimism in the industry is rising.